Bone marrow transplantation. Part II--autologous.
Autologous bone marrow transplantation provides an effective form of "rescue" following high-dose therapy used for treating certain malignant diseases. The high doses of radiotherapy or chemotherapy, or both, should allow for greater tumor cell kill if dose-response to therapy exists for that tumor. The use of autologous bone marrow obviates the need for an HLA-identical donor, and the need for pretransplant immunosuppression; no graft-versus-host disease would ensue. We review in part II the history and background, methods of obtaining autologous stem cells, and details of the results achievable with this type of therapy. We discuss potential difficulties with autologous transplantation, as well as possible future areas of research.
Department of Medicine, Stanford University School of Medicine, CA.
N J
NJ
Chao
K G
KG
Blume
D016026:Bone Marrow Transplantation / Q000639:trends; D005544:Forecasting; D006689:Hodgkin Disease / Q000601:surgery; D006801:Humans; D007938:Leukemia / Q000601:surgery; D008223:Lymphoma / Q000601:surgery; D009369:Neoplasms / Q000601:surgery*; D014182:Transplantation, Autologous